IART
Integra LifeSciences Holdings Corporation (IART)
NASDAQ · Healthcare
Integra LifeSciences Holdings Corporation annual/quarterly long term debt history from 2018 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Integra LifeSciences Holdings Corporation long term debt for the quarter ending December 31, 2025 were 726.6M, a 4.46% decrease year-over-year.
- Integra LifeSciences Holdings Corporation long term debt for 2025 were 726.6M, a 4.46% decrease from 2024.
- Integra LifeSciences Holdings Corporation long term debt for 2024 were 760.5M, a 1.87% decrease from 2023.
- Integra LifeSciences Holdings Corporation long term debt for 2023 were 775.0M, a 0.00% increase from 2022.
- Integra LifeSciences Holdings Corporation long term debt for 2022 were 775.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Integra LifeSciences Holdings Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $727 |
| 2024 | $760 |
| 2023 | $775 |
| 2022 | $775 |
| 2021 | $844 |
| 2020 | $878 |
| 2019 | $878 |
| 2018 | $900 |
| Integra LifeSciences Holdings Corporation Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $727 |
| 2024-12-31 | $760 |
| 2023-12-31 | $775 |
| 2022-12-31 | $775 |
| 2021-12-31 | $844 |
| 2020-12-31 | $878 |
| 2019-12-31 | $878 |
| 2018-12-31 | $900 |
Integra LifeSciences Holdings Corporation Long Term Debt — FAQ
Integra LifeSciences Holdings Corporation (IART) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IART's long term debt history?
The chart and table above show Integra LifeSciences Holdings Corporation's long term debt by year and by quarter, including the growth rate.